Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Expected to Announce Earnings of $0.38 Per Share

Analysts expect that Sabra Health Care REIT, Inc. (NASDAQ:SBRAGet Rating) will post earnings of $0.38 per share for the current fiscal quarter, according to Zacks. Five analysts have provided estimates for Sabra Health Care REIT’s earnings, with the lowest EPS estimate coming in at $0.37 and the highest estimate coming in at $0.41. Sabra Health Care REIT reported earnings of $0.39 per share during the same quarter last year, which would suggest a negative year-over-year growth rate of 2.6%. The firm is scheduled to issue its next quarterly earnings report after the market closes on Monday, January 1st.

On average, analysts expect that Sabra Health Care REIT will report full-year earnings of $1.53 per share for the current financial year, with EPS estimates ranging from $1.49 to $1.62. For the next fiscal year, analysts expect that the company will post earnings of $1.56 per share, with EPS estimates ranging from $1.46 to $1.66. Zacks’ EPS averages are an average based on a survey of sell-side research analysts that follow Sabra Health Care REIT.

Sabra Health Care REIT (NASDAQ:SBRAGet Rating) last posted its quarterly earnings results on Monday, February 21st. The real estate investment trust reported ($0.11) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.35 by ($0.46). Sabra Health Care REIT had a negative net margin of 19.89% and a negative return on equity of 3.33%. During the same period in the prior year, the firm posted $0.42 earnings per share.

A number of brokerages have commented on SBRA. KeyCorp started coverage on Sabra Health Care REIT in a research note on Friday, February 18th. They issued a “sector weight” rating on the stock. Mizuho cut their price objective on Sabra Health Care REIT from $18.00 to $16.00 in a research report on Thursday, January 20th. Stifel Nicolaus cut their target price on shares of Sabra Health Care REIT from $21.00 to $18.00 and set a “buy” rating for the company in a research note on Wednesday, February 23rd. Credit Suisse Group upped their price target on Sabra Health Care REIT from $14.00 to $15.00 and gave the company a “neutral” rating in a report on Monday, April 4th. Finally, JMP Securities reduced their price objective on shares of Sabra Health Care REIT from $20.00 to $16.00 and set a “buy” rating for the company in a report on Tuesday, February 15th. Six equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $16.60.

Shares of SBRA stock opened at $12.14 on Monday. The company has a current ratio of 3.60, a quick ratio of 3.60 and a debt-to-equity ratio of 0.71. Sabra Health Care REIT has a 1-year low of $12.12 and a 1-year high of $19.01. The stock’s fifty day simple moving average is $13.66 and its 200-day simple moving average is $13.79. The company has a market capitalization of $2.80 billion, a price-to-earnings ratio of -23.80 and a beta of 1.37.

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 28th. Shareholders of record on Friday, February 11th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 9.88%. The ex-dividend date of this dividend was Thursday, February 10th. Sabra Health Care REIT’s payout ratio is presently -235.29%.

Several hedge funds have recently made changes to their positions in the company. Signaturefd LLC raised its position in Sabra Health Care REIT by 250.9% in the 4th quarter. Signaturefd LLC now owns 2,516 shares of the real estate investment trust’s stock worth $34,000 after purchasing an additional 1,799 shares during the last quarter. Ellevest Inc. acquired a new position in shares of Sabra Health Care REIT during the fourth quarter valued at $37,000. Future Financial Wealth Managment LLC bought a new position in Sabra Health Care REIT in the fourth quarter valued at about $41,000. PSI Advisors LLC acquired a new stake in Sabra Health Care REIT in the third quarter worth about $63,000. Finally, Penserra Capital Management LLC bought a new stake in Sabra Health Care REIT during the 3rd quarter worth about $76,000. Institutional investors own 84.53% of the company’s stock.

Sabra Health Care REIT Company Profile (Get Rating)

As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 Skilled Nursing/Transitional Care facilities, (ii) 64 Senior Housing communities (ÂSenior Housing – LeasedÂ), (iii) 47 Senior Housing communities operated by third-party property managers pursuant to property management agreements (ÂSenior Housing – ManagedÂ) and (iv) 27 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 19 investments in loans receivable (consisting of (i) one mortgage loan, (ii) one construction loan and (iii) 17 other loans), six preferred equity investments and one investment in an unconsolidated joint venture that owns 158 Senior Housing – Managed communities.

See Also

Get a free copy of the Zacks research report on Sabra Health Care REIT (SBRA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.